Scholars Central

Short communicationPublished 29 Jul 2021

Lobectomy versus Stereotactic Ablative Radiotherapy for Medically Operable Patients with Stage IA Non-Small Cell Lung Cancer: A Virtual Randomized Phase III Trial Stratified by Age

Authors: Young-Seok Seo

Journal of Pulmonology

Volume 5 · Issue 1 · Pages 4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Although the choice between stereotactic ablative radiotherapy (SABR) and lobectomy for early-stage NSCLC has been debated for years, the two procedures have not yet been directly compared in a randomized trial. We conducted a virtual randomized phase III trial stratified by age to compare the effectiveness of lobectomy and SABR for medically operable patients with stage IA (AJCC 8th) non-small cell lung cancer NSCLC using the Markov model analysis. Methods: A Markov model was developed to simulate a cohort of patients aged 45–85 years with stage IA NSCLC who had undergone either lobectomy or SABR and were followed up for their remaining lifetime (Figure 1). Each virtual patient was randomly assigned to undergo lobectomy or SABR, and 10,000 patients were allocated to each group. All of the estimates of the variables were obtained by a systematic review of published articles. Results: The lobectomy group showed a better life expectancy than the SABR group, in patients under 75 years of age (Table 1). However, no statistically significant difference was seen in patients 75 years or older. The predicted life expectancy was 9.43 and 8.70 years in 75-year-old patients in the lobectomy and SABR groups, respectively. However, the 95% CI for the difference in life expectancy between the two groups was - 0.06 to 1.50 years (p = 0.0689). Conclusions: The Markov model showed no statistically significant difference in the expected overall survival in stage IA NSCLC patients who were older than 75 years and had undergone SABR or lobectomy. Figure 1. A Scenario for the Markov state transition model of NSCLC less than 3 cm Each rectangle represents a state of health. From the initial state, patients are randomized to undergo lobectomy or SABR. Straight arrows represent the changes that may occur during each cycle or a very short time interval. In contrast, gray rectangles mean that the patients may remain in the same Markov state for more than one cycle. NSCLC; non-small cell lung cancer, SABR; stereotactic ablative radiotherapy, CTx; chemotherapy, RT; conventional radiotherapy, pN+; pathologically positive lymph node, NED; no evidence of disease, BSC; best supportive care

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pulmonology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pulmonology
  • SubjectPulmonology & Respiratory
  • BylineArticles whose byline prints “Young-Seok Seo”